| 000 | 00943 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250516083706.0 | ||
| 264 | 0 | _c20120524 | |
| 008 | 201205s 0 0 eng d | ||
| 022 | _a1873-281X | ||
| 024 | 7 |
_a10.1016/S1472-9792(12)70004-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSmall, Peter M | |
| 245 | 0 | 0 |
_aPlanning in the context of a virtuous cycle for tuberculosis vaccine development. _h[electronic resource] |
| 260 |
_bTuberculosis (Edinburgh, Scotland) _cMar 2012 |
||
| 300 |
_aS4-5 p. _bdigital |
||
| 500 | _aPublication Type: Editorial | ||
| 650 | 0 | 4 |
_aClinical Trials as Topic _xtrends |
| 650 | 0 | 4 |
_aDrug Discovery _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aTuberculosis _ximmunology |
| 650 | 0 | 4 |
_aTuberculosis Vaccines _ximmunology |
| 773 | 0 |
_tTuberculosis (Edinburgh, Scotland) _gvol. 92 Suppl 1 _gp. S4-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S1472-9792(12)70004-5 _zAvailable from publisher's website |
| 999 |
_c21644902 _d21644902 |
||